Navigation Links
Johns Hopkins Medicine expands reach in Latin America
Date:2/11/2013

World-class standards for clinical outcomes and patient safety are at the core of a landmark affiliation agreement signed today between Johns Hopkins Medicine International (JHI) and Pacfico S.A. Entidad Prestadora de Salud (Pacfico Salud), a Lima, Peru-based subsidiary of Credicorp Ltd. (NYSE: BAP).

The collaboration focuses on a network of Peruvian hospitals, an oncology clinic, clinical and pathology laboratories, and outpatient centers that have recently been acquired by Pacfico Salud.

"This important endeavor is designed to raise the quality of health care services across a vast and committed corps of caregivers," says Steven J. Thompson, chief executive officer of Johns Hopkins Medicine International. "We believe that it will have significant long-term impact on Peruvian health care and are pleased to have the opportunity to collaborate with our colleagues at Pacfico Salud, and to share our innovations and best practices with health care providers in this dynamic country and beyond."

Under the terms of the agreement, which was signed in Baltimore, USA, the two organizations will focus on health system strengthening through patient safety and operational and service efficiencies. Johns Hopkins experts will work together with their Peruvian colleagues in the development of clinical and patient services programs, infection control initiatives, and quality improvement processes. The affiliation will also focus on elevating nursing and introducing innovative care concepts.

The new collaboration also aims to create an enhanced infrastructure for the delivery of patient care. At the same time, it provides a viable platform from which to launch a number of public health-focused programs related to the prevention and early detection of non-communicable diseases.

Accreditation of the network hospitals, outpatient and laboratories will be another primary goal. Currently, there are no Joint Commission International-accredited hospitals in a nation with more than 30 million citizens.

"We are very proud to have signed this agreement. It represents a turning point in the history of Peruvian health care, allowing us to be one of the driving forces of its improvement," says Guillermo Garrido Lecca, general manager of Pacfico Salud. "Through our continued collaboration and knowledge transfer initiatives with a world leader in academic medicine, we aim to become the model for local and international health care institutions."

The affiliation agreement with Johns Hopkins Medicine International is the first of its kind in Peru, one of Latin America's fastest growing economies. It also represents a major step forward for Pacfico Salud as it advances its leadership role in the Peruvian private health care realm.

The two organizations began their collaboration in 2012 with a series of activities that included an assessment of Pacfico Salud's health care facilities and an intensive training program for its leaders in health care finance and management. Pacfico Salud currently operates five inpatient facilities across the country.


'/>"/>

Contact: Natalia Bolotina
nboloti1@jhmi.edu
928-266-6318
Johns Hopkins Medicine
Source:Eurekalert

Related medicine news :

1. 29 Johns Hopkins stem cell researchers awarded funding
2. Johns Hopkins African bioethics program receives 5-year continuation grant from NIH
3. Johnson & Johnson Violated FDA Order to Halt Sales of Transvaginal Mesh
4. Johns Hopkins researchers return blood cells to stem cell state
5. Johns Hopkins team finds ICU misdiagnoses may account for as many annual deaths as breast cancer
6. Johns Hopkins Armstrong Institute receives $8.9 million patient safety grant
7. Results from study of Mead Johnsons Enfamil® Human Milk Fortifier Acidified Liquid published in Pediatrics
8. Johns Hopkins scientists pair blood test and gene sequencing to detect cancer
9. The US Drug Watchdog Now Urges Women Who Suffered A Heart Attack Or Stroke After Using Yaz Yasmin Birth Control Pills To Contact The Johnson Law Group Immediately
10. The US Drug Watchdog Now Urges Any Woman Who Used The Birth Control Pills Yaz Or Yasmin And Then Had A Heart Attack Or Stroke To Call The Johnson Law Group----ASAP
11. In US first, Johns Hopkins surgeons implant brain pacemaker for Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... , ... April 21, 2017 , ... Providing broad access ... in opposition, but there is a better way to address this problem. , That ... of Pharmacy, Public Policy and Economics at the University of Southern California, who served ...
(Date:4/21/2017)... ... , ... Brady (NYSE:BRC), a global leader in industrial and safety ... vinyl label materials received certification for the BS5609 British Marine Standard. This internationally ... legible, for use on chemical drums shipped by sea. , “Achieving BS5609 ...
(Date:4/21/2017)... ... April 21, 2017 , ... The VIA Agency , ... for Theravent, Inc. , the makers of a revolutionary new device clinically ... is now working to expand distribution in anticipation of a national launch. VIA ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... announced an exciting new partnership with the highly regarded and well renowned Asian ... highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and ...
(Date:4/21/2017)... ... April 21, 2017 , ... BrightStar Care Salt Lake City, a home ... of Utah (APCUT) and has appointed Rex Wheeler as its new Director of Business ... our agency and our ability to provide quality care to the community,” said Tammara ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: